Search

Stryker Corp

Atidarymo kaina

SektoriusSveikatos priežiūra

337.76 -0.9

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

334.39

Max

341.74

Pagrindiniai rodikliai

By Trading Economics

Pajamos

531M

1.3B

Pardavimai

569M

6.6B

P/E

Sektoriaus vid.

35.072

57.002

Pelnas, tenkantis vienai akcijai

3.69

Dividendų pajamingumas

1.03

Pelno marža

19.366

Darbuotojai

56,000

EBITDA

266M

1.6B

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+12.82% upside

Dividendai

By Acuity

Dividendų pajamingumas

Sektoriaus vid.

1.03%

2.22%

Kitas uždarbis

2026-10-29

Kitas dividendų mokėjimo data

2026-10-30

Kita Ex Dividend data

2026-09-29

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

3.6B

133B

Ankstesnė atidarymo kaina

338.66

Ankstesnė uždarymo kaina

337.76

Naujienos nuotaikos

By Acuity

61%

39%

296 / 340 reitingas Healthcare

Stryker Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-13 20:06; UTC

News

Stryker Corp shares declined following Wolfe Research's downgrade to Peer Perform, citing a challenging outlook and tempered growth expectations for the second half of the year.

2026-08-12 19:16; UTC

Stryker Corp. shares are lower amid geopolitical tensions and rising crude oil prices, despite remaining above their 20-day moving average.

2026-08-11 23:26; UTC

Stryker Corp. shares declined in after-market trading, reflecting broader market trends amid cautious investor sentiment and lower oil prices.

2026-08-10 23:06; UTC

Stryker Corp shares are higher in after-market trading, continuing a trend above the 20-day moving average after three consecutive sessions of gains.

2026-08-07 20:06; UTC

Stryker Corp shares are higher, supported by declining Treasury yields after July's unemployment rate fell to 4.1%. Earlier, the stock pulled back from session lows.

2026-08-06 20:06; UTC

Macro Event
News

Stryker Corp shares are lower as supply chain disruptions impact sales, despite meeting revenue expectations of $6.59 billion and adjusted EPS of $3.69.

2026-08-05 23:12; UTC

Stryker Corp shares are lower in after-market hours, reflecting unusual trading behavior and a decline in momentum since Wednesday's close. No specific news was identified.

2026-08-04 19:56; UTC

Stryker Corp shares are lower today, reflecting broader market trends amid a significant drop in crude oil prices since Monday's close.

2026-08-03 20:03; UTC

News

Stryker Corp shares are higher as Citizens lowers its price target to $400, citing strong Q2 revenue growth despite supply chain challenges.

2026-07-31 23:16; UTC

Stryker Corp shares are higher in after-market trading, showing some volatility. No specific company news has been identified to explain the movement.

2026-07-30 23:41; UTC

Social Media
News

Stryker Corp shares fell in after-market trading despite reporting adjusted EPS of $3.69 and raising full-year guidance to $14.95 to $15.10.

2026-07-29 22:41; UTC

Stryker Corp shares are lower in after-market trading, reversing from earlier gains. The stock remains above its 20-day moving average.

2026-07-28 20:51; UTC

Stryker Corp shares are lower in after-market trading, reversing earlier gains. The stock remains above its 20-day moving average.

2026-07-27 19:06; UTC

Social Media
News
Correlated Moves

Stryker Corp shares reached a 13-week high today, trading higher alongside broader gains in the medical technology sector, including Intuitive Surgical's notable increase.

2026-07-24 23:36; UTC

Stryker Corp shares are lower in after-market hours, with no specific news identified. Market sentiment reflects cautious optimism amid a decrease in initial jobless claims.

2026-07-22 20:46; UTC

Stryker Corp. shares are higher in after-market trading, rebounding from recent declines, though still below the 20-day moving average.

2026-07-21 18:16; UTC

Stryker Corp shares are lower today, following a dip that reached nearly -2%. The stock remains below its 20-day moving average.

2026-07-20 20:41; UTC

Stryker Corp shares are lower in after-market hours with no specific news identified. Broader market dynamics include a decline in the US 10Y Treasury yield.

Akcijų palyginimas

Kainos pokytis

Stryker Corp Prognozė

Kainos tikslas

By TipRanks

12.82% į viršų

12 mėnesių prognozė

Vidutinis 384.82 USD  12.82%

Aukščiausias 455 USD

Žemiausias 340 USD

Remiantis 18 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Stryker Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

18 ratings

16

Pirkti

2

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

296 / 340 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Meškų rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
help-icon Live chat